A case of diffuse peritoneal malignant mesothelioma - Intraabdominal administration of cisplatin is useful for diminishing ascites

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 10, 2010, Pages 1975-1978

  Noguchi, Tadaaki ^a   Kawamura, Muneo ^a   Kawamura, Takeshi ^a   Shimamura, Takahiro ^a   Sasaki, Kuniaki ^a   Hosono, Tomohiro ^a   Sato, Rikiya ^a   Murakami, Keishiro ^a  

^a Kawamura Hospital   (Japan)

Author keywords

Ascites; Cisplatin; Diffuse malignant peritoneal mesothelioma

Indexed keywords

CISPLATIN; HYALURONIC ACID;

ABDOMINAL DISTENSION; ADULT; ARTICLE; ASCITES; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CASE REPORT; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; HUMAN; HUMAN TISSUE; LAPAROSCOPY; LIVER METASTASIS; MALE; PERITONEAL BIOPSY; PERITONEUM MESOTHELIOMA; PLEURA MESOTHELIOMA;

EID: 79960765711     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Wagner JC, Sleggs CA and Marchand P: Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 17: 260-271, 1960.
2. Kalmadi SR, Rankin C, Kraut MJ, et al: Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG9810). Lung Cancer 60(2) : 259-263, 2008. (Pubitemid 351609140)
3. Sugarbaker PH, Yan TD, Stuat OA, et al: Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol 32(6): 686-691, 2006. (Pubitemid 44063999)